149 related articles for article (PubMed ID: 25594895)
1. Isolation, LC-MS/MS and 2D-NMR characterization of alkaline degradants of tenofovir disoproxil fumarate.
Anandgaonkar V; Gupta A; Kona S; Talluri MV
J Pharm Biomed Anal; 2015 Mar; 107():175-85. PubMed ID: 25594895
[TBL] [Abstract][Full Text] [Related]
2. Degradants of Tenofovir Disoproxil Fumarate Under Forced Yet Mild Thermal Stress: Isolation, Comprehensive Structural Elucidation, and Mechanism.
Ranga M; Modini AK; Nallajarla AK; Doddipalla R; Kaliyaperumal M; Goswami A
AAPS PharmSciTech; 2023 Jun; 24(6):139. PubMed ID: 37349667
[TBL] [Abstract][Full Text] [Related]
3. Stability behaviour of antiretroviral drugs and their combinations. 2: Characterization of interaction products of lamivudine and tenofovir disoproxil fumarate by mass and NMR spectrometry.
Kurmi M; Kushwah BS; Sahu A; Narayanam M; Singh S
J Pharm Biomed Anal; 2016 Jun; 125():245-59. PubMed ID: 27042808
[TBL] [Abstract][Full Text] [Related]
4. Forced degradation and impurity profiling: recent trends in analytical perspectives.
Jain D; Basniwal PK
J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous determination of pradefovir, PMEA and tenofovir in HBV patient serum using liquid chromatography-tandem mass spectrometry and application to phase 2 clinical trial.
Xiao Q; Wang D; Yang W; Chen L; Ding Y; Yang J
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jun; 1022():133-140. PubMed ID: 27089519
[TBL] [Abstract][Full Text] [Related]
6. Identification, synthesis and characterization of new impurities in tenofovir.
He Z; He Z; Wei C; Gao H; Li Y; Che D
Pharmazie; 2015 May; 70(5):283-8. PubMed ID: 26062294
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetics of tenofovir in Beagle dogs after oral dosing of tenofovir dipivoxil fumarate using HPLC-MS/MS analysis].
Wang BL; Hu JP; Sheng L; Chen H; Li Y
Yao Xue Xue Bao; 2013 Mar; 48(3):390-4. PubMed ID: 23724653
[TBL] [Abstract][Full Text] [Related]
8. Stability behaviour of antiretroviral drugs and their combinations. 4: Characterization of degradation products of tenofovir alafenamide fumarate and comparison of its degradation and stability behaviour with tenofovir disoproxil fumarate.
Golla VM; Kurmi M; Shaik K; Singh S
J Pharm Biomed Anal; 2016 Nov; 131():146-155. PubMed ID: 27589032
[TBL] [Abstract][Full Text] [Related]
9. Isolation and structure elucidation of major alkaline degradant of ezetimibe.
Gajjar AK; Shah VD
J Pharm Biomed Anal; 2011 Apr; 55(1):225-9. PubMed ID: 21288678
[TBL] [Abstract][Full Text] [Related]
10. Determination of enantiomeric impurity of tenofovir disoproxil fumarate on a cellulose tris(3,5-dichlorophenyl-carbamate) chiral stationary phase and the characterization of its related substances.
Nguyen BT; Le TA; Mai XL; Nguyen TNV; Phan TD; Kang JS; Kim KH
J Sep Sci; 2021 May; 44(10):2029-2036. PubMed ID: 33682357
[TBL] [Abstract][Full Text] [Related]
11. Critical practical aspects in the application of liquid chromatography-mass spectrometric studies for the characterization of impurities and degradation products.
Narayanam M; Handa T; Sharma P; Jhajra S; Muthe PK; Dappili PK; Shah RP; Singh S
J Pharm Biomed Anal; 2014 Jan; 87():191-217. PubMed ID: 23706957
[TBL] [Abstract][Full Text] [Related]
12. Validated stability indicating assay method of olaparib: LC-ESI-Q-TOF-MS/MS and NMR studies for characterization of its new hydrolytic and oxidative forced degradation products.
Thummar M; Kuswah BS; Samanthula G; Bulbake U; Gour J; Khan W
J Pharm Biomed Anal; 2018 Oct; 160():89-98. PubMed ID: 30075398
[TBL] [Abstract][Full Text] [Related]
13. Stress studies of tenofovir disoproxil fumarate by HPTLC in bulk drug and pharmaceutical formulation.
Havele S; Dhaneshwar SR
ScientificWorldJournal; 2012; 2012():894136. PubMed ID: 22606065
[TBL] [Abstract][Full Text] [Related]
14. Stability-indicating HPLC method development and structural elucidation of novel degradation products in posaconazole injection by LC-TOF/MS, LC-MS/MS and NMR.
Yang Y; Zhu X; Zhang F; Li W; Wu Y; Ding L
J Pharm Biomed Anal; 2016 Jun; 125():165-77. PubMed ID: 27023129
[TBL] [Abstract][Full Text] [Related]
15. LC-ESI-QTOF-MS analysis utilizing gas-phase fragmentation reactions subjected to ESI-IS-CID and ESI-CID-MS/MS conditions to study the degradation behaviour of sorafenib tosylate: NMR and in vitro cytotoxicity and apoptosis detection studies of hydrolytic degradation products.
Johnsirani P; Wani AA; Bharatam PV; Nanjappan S
J Pharm Biomed Anal; 2020 Jan; 177():112881. PubMed ID: 31542419
[TBL] [Abstract][Full Text] [Related]
16. Reversed-phase liquid chromatography with electrospray mass detection and 1H and 13C NMR characterization of new process-related impurities, including forced degradants of efavirenz: related substances correlated to the synthetic pathway.
Gadapayale K; Kakde R; Sarma VU
J Sep Sci; 2015 Jan; 38(2):218-30. PubMed ID: 25385054
[TBL] [Abstract][Full Text] [Related]
17. Structural identification and characterization of potential degradants of zotarolimus on zotarolimus-coated drug-eluting stents.
Chen Q; Zielinski D; Chen J; Nowak S; Zhou CC
J Pharm Biomed Anal; 2009 Dec; 50(5):778-86. PubMed ID: 19581067
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of stress degradation products of sumatriptan succinate by using LC/Q-TOF-ESI-MS/MS and NMR: Toxicity evaluation of degradation products.
Udutha S; Shankar G; Borkar RM; Kumar K; Srinivasulu G; Guntuku L; Naidu VGM; Srinivas R
J Mass Spectrom; 2018 Oct; 53(10):963-975. PubMed ID: 29987857
[TBL] [Abstract][Full Text] [Related]
19. Organic vapor sorption method of isostructural solvates and polymorph of tenofovir disoproxil fumarate.
Lee J; Boerrigter SX; Jung YW; Byun Y; Yuk SH; Byrn SR; Lee EH
Eur J Pharm Sci; 2013 Nov; 50(3-4):253-62. PubMed ID: 23872626
[TBL] [Abstract][Full Text] [Related]
20. Stability behaviour of antiretroviral drugs and their combinations. 3: Characterization of interaction products of emtricitabine and tenofovir disoproxil fumarate by mass spectrometry.
Kurmi M; Singh DK; Tiwari S; Sharma P; Singh S
J Pharm Biomed Anal; 2016 Sep; 128():438-446. PubMed ID: 27344633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
